Patheon OneSource™

Integrated Drug Development and Clinical Services for Small and Emerging Pharma

The path through drug development is marked by detours, roadblocks and very few shortcuts. At times you may feel that you’re the only person keeping your molecule on its critical path. Unexpected delays can lead to missed milestones, rework and delayed timelines – all setbacks that no one wants to explain to their investors. Patheon OneSource™ delivers a streamlined drug development program, designed specifically for small and emerging companies. This program combines your drug substance and drug product development and clinical manufacturing into a single solution to accelerate your discovery to proof of concept.

By working with Patheon CDMO services within Thermo Fisher Scientific, you position your molecule for greater therapeutic and financial success because it has been formulated with scale-up in mind. In fact, our clients have reduced their development timelines by an average of 13 weeks, equating to an average of approximately $44 million in development time costs, as reported by the Tufts Center for the Study of Drug Development.

Learn more about Patheon OneSource™ by downloading our Patheon OneSource™ Information Sheet.

Contact us to find out if Patheon OneSource™ is the right fit for your next project.